These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15831362)
1. Association of interleukin-6 gene G-174C polymorphism and plasma plasminogen activator inhibitor-1 level in Chinese patients with and without hypertension. Jeng JR; Wang JH; Liu WS; Chen SP; Chen MY; Wu MH; Hsu WL; Lin SZ Am J Hypertens; 2005 Apr; 18(4 Pt 1):517-22. PubMed ID: 15831362 [TBL] [Abstract][Full Text] [Related]
2. Association of PAI-1 gene promoter 4g/5g polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension. Jeng JR Am J Hypertens; 2003 Apr; 16(4):290-6. PubMed ID: 12670745 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin, T94G gene polymorphism and PAI-1 in patients with and without hypertension. Jeng JR Cardiology; 2007; 107(1):30-7. PubMed ID: 16741355 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension. Jeng JR; Harn HJ; Yueh KC; Jeng CY; Shieh SM Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054 [TBL] [Abstract][Full Text] [Related]
5. [Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension]. Zhang YL; Zhou SX; Lei J; Zhang JM Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1681-4. PubMed ID: 18024289 [TBL] [Abstract][Full Text] [Related]
6. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia]. Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596 [TBL] [Abstract][Full Text] [Related]
7. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Kim DK; Kim JW; Kim S; Gwon HC; Ryu JC; Huh JE; Choo JA; Choi Y; Rhee CH; Lee WR Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3242-7. PubMed ID: 9409318 [TBL] [Abstract][Full Text] [Related]
9. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232 [TBL] [Abstract][Full Text] [Related]
10. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension]. Song Y; Xu W; Chen Y; Che L; Wang Q; Zhou X; Wu J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):374-6. PubMed ID: 10581347 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population. Matsubara Y; Hayakawa T; Tsuda T; Takeshita E; Watanabe G; Murata M; Watanabe K; Ikeda Y Blood Coagul Fibrinolysis; 2000 Mar; 11(2):115-20. PubMed ID: 10759003 [TBL] [Abstract][Full Text] [Related]
12. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Nagi DK; Foy CA; Mohamed-Ali V; Yudkin JS; Grant PJ; Knowler WC Metabolism; 1998 May; 47(5):622-6. PubMed ID: 9591757 [TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients. Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 G-174C gene polymorphism and serum resistin levels in North Indian women: potential risk of metabolic syndrome. Gupta A; Gupta V; Singh AK; Tiwari S; Agrawal S; Natu SM; Agrawal CG; Negi MP; Pant AB Hum Exp Toxicol; 2011 Oct; 30(10):1445-53. PubMed ID: 21177727 [TBL] [Abstract][Full Text] [Related]
16. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion. von Känel R; Maly FE; Frey K; Fischer JE Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709 [TBL] [Abstract][Full Text] [Related]
17. Role of fibrinolytic parameters and plasminogen activator inhibitor 1 (PAI-1) promoter polymorphism on premature atherosclerosis in SLE patients. Bicakcigil M; Tasan D; Tasdelen N; Mutlu N; Yavuz S Lupus; 2011 Oct; 20(10):1063-71. PubMed ID: 21719525 [TBL] [Abstract][Full Text] [Related]
18. Association of Interleukin-6 Genetic Polymorphisms (rs1800795, -174C > G and rs1800796, -572G > C) With Risk of Essential Hypertension in the Chinese Population. Ren H; Guo Z; Qin WJ; Yang ZL Cureus; 2023 Oct; 15(10):e46334. PubMed ID: 37920615 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis. Li YY PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752 [TBL] [Abstract][Full Text] [Related]
20. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women. Kim KN; Kim KM; Kim BT; Joo NS; Cho DY; Lee DJ Chin Med J (Engl); 2012 Apr; 125(7):1249-53. PubMed ID: 22613596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]